🟢 Telix Pharmaceuticals is trading 5.01% up today following proposed US$1.65 billion ITM acquisition

Telix Pharmaceuticals is trading at A$16.55, +5.01%, following its proposed acquisition of Germany’s ITM Isotope Technologies Munich for US$1.65 billion upfront.

• Reuters reported the transaction is intended to expand Telix’s radiopharmaceutical capabilities
• Bloomberg said the deal could reach US$2.35 billion with milestone payments
• The transaction involves approximately US$1.25 billion in Telix shares and assumed ITM debt